Federal contract award
75F40121C00196
TTIMS LRCC REQUIREMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | B599 — Other Special Studies and Analysis |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $7.3M |
| Current contract value | $7.3M |
| Potential contract value / ceiling | $7.3M |
| Start date | Sep 27, 2021 |
| Current end date | Sep 29, 2025 |
| Potential end date | Sep 29, 2025 |
| Latest award activity | Aug 19, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 19, 2024 | P00005 | $1.6M | TTIMS LRCC REQUIREMENT |
| Jul 24, 2023 | P00004 | $1.9M | TTIMS LRCC REQUIREMENT |
| Mar 2, 2023 | P00003 | $0 | TTIMS LRCC REQUIREMENT |
| Sep 24, 2022 | P00002 | $2.0M | TTIMS LRCC REQUIREMENT |
| Nov 17, 2021 | P00001 | $0 | EO14042 TTIMS LRCC REQUIREMENT |
| Sep 27, 2021 | 0 | $1.9M | TTIMS LRCC REQUIREMENT |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Howard S. Yablon | Contact | howard.yablon@fda.hhs.gov 2404027630 | Source | Sep 2, 2021 |
| Howard S. Yablon | Contact | howard.yablon@fda.hhs.gov 2404027630 | Source | Sep 2, 2021 |
| Howard S. Yablon | Contact | howard.yablon@fda.hhs.gov 2404027630 | Source | Sep 2, 2021 |
| Howard S. Yablon | Contact | howard.yablon@fda.hhs.gov 2404027630 | Source | Sep 2, 2021 |
| Howard S. Yablon | Contact | howard.yablon@fda.hhs.gov 2404027630 | Source | Aug 22, 2021 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.